Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK, Safety, and Efficacy of Vatiquinone in Children < 7 Years with Friedreich Ataxia
NCT05485987Phase 2Completed
- Sponsor
- PTC Therapeutics, Inc.
- Start
- Oct 2022
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vatiquinone in Friedreich ataxia (FA), sponsored by PTC Therapeutics, Inc.. Started Oct 2022; status: completed.
02
Drugs
vatiquinone
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on NCT05485987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05485987.